The Role of Patient Religiosity in the Evaluation and Treatment Outcomes for Chronic HCV Infection

Rajeev Raghavan, Laura Ferlic-Stark, Cinda Clarke, Manish Rungta, Richard Goodgame

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

To determine the influence of patient religiosity on the outcome of treatment of hepatitis C infection, a prospective, blinded, cohort study was performed on hepatitis C-infected patients categorized as 'higher religiosity' and 'lower religiosity' based on responses to a religiosity questionnaire. Comparisons were made between high and low religiosity patients on demographics, pre-treatment laboratory values, and response to treatment. Eighty-seven patients with complete questionnaires were placed in either higher (38) or lower (49) religiosity cohort. The patients (60% female) were ethnically diverse: African-American 39%; Hispanic 31%; white 29%. African-American race (P = 0. 001) and female gender (P = 0. 026) were associated with higher religiosity. The frequency of being offered treatment, accepting treatment, and completing treatment was similar in both religiosity cohorts (P = 0. 234, 0. 809, 0. 367). Fifty-six patients completed the 24- or 48-week treatment with peginterferon and ribavirin. Depression was more frequent in the low religiosity group (38. 2% vs. 4. 6%, P = 0. 005). Sustained viral response rate at 3-6-month post-therapy was similar in the higher (50%) and lower (57. 6%) religiosity cohorts (P = 0. 580; n = 55). Logistic regression modeling revealed that males having higher religiosity gave greater odds of SVR than those with lower religiosity (OR 21. 3; 95% CI 1. 1-403. 9). The level of religiosity did not affect the decision to begin treatment for chronic HCV infection and was not associated with a better treatment outcome. A higher level of religiosity was associated with less depression among patients.

Original languageEnglish (US)
Pages (from-to)79-90
Number of pages12
JournalJournal of Religion and Health
Volume52
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Infection
Therapeutics
Hepatitis C
African Americans
Religiosity
Treatment Outcome
Evaluation
Ribavirin
Hispanic Americans
Cohort Studies
Logistic Models
Demography
Cohort
Surveys and Questionnaires

Keywords

  • HCV
  • Hepatitis C virus
  • Religion
  • Religiosity
  • SF-36

ASJC Scopus subject areas

  • Religious studies
  • Medicine(all)
  • Nursing(all)

Cite this

The Role of Patient Religiosity in the Evaluation and Treatment Outcomes for Chronic HCV Infection. / Raghavan, Rajeev; Ferlic-Stark, Laura; Clarke, Cinda; Rungta, Manish; Goodgame, Richard.

In: Journal of Religion and Health, Vol. 52, No. 1, 2013, p. 79-90.

Research output: Contribution to journalArticle

Raghavan, Rajeev ; Ferlic-Stark, Laura ; Clarke, Cinda ; Rungta, Manish ; Goodgame, Richard. / The Role of Patient Religiosity in the Evaluation and Treatment Outcomes for Chronic HCV Infection. In: Journal of Religion and Health. 2013 ; Vol. 52, No. 1. pp. 79-90.
@article{7198738694e042b6872fecaf87d3a69c,
title = "The Role of Patient Religiosity in the Evaluation and Treatment Outcomes for Chronic HCV Infection",
abstract = "To determine the influence of patient religiosity on the outcome of treatment of hepatitis C infection, a prospective, blinded, cohort study was performed on hepatitis C-infected patients categorized as 'higher religiosity' and 'lower religiosity' based on responses to a religiosity questionnaire. Comparisons were made between high and low religiosity patients on demographics, pre-treatment laboratory values, and response to treatment. Eighty-seven patients with complete questionnaires were placed in either higher (38) or lower (49) religiosity cohort. The patients (60{\%} female) were ethnically diverse: African-American 39{\%}; Hispanic 31{\%}; white 29{\%}. African-American race (P = 0. 001) and female gender (P = 0. 026) were associated with higher religiosity. The frequency of being offered treatment, accepting treatment, and completing treatment was similar in both religiosity cohorts (P = 0. 234, 0. 809, 0. 367). Fifty-six patients completed the 24- or 48-week treatment with peginterferon and ribavirin. Depression was more frequent in the low religiosity group (38. 2{\%} vs. 4. 6{\%}, P = 0. 005). Sustained viral response rate at 3-6-month post-therapy was similar in the higher (50{\%}) and lower (57. 6{\%}) religiosity cohorts (P = 0. 580; n = 55). Logistic regression modeling revealed that males having higher religiosity gave greater odds of SVR than those with lower religiosity (OR 21. 3; 95{\%} CI 1. 1-403. 9). The level of religiosity did not affect the decision to begin treatment for chronic HCV infection and was not associated with a better treatment outcome. A higher level of religiosity was associated with less depression among patients.",
keywords = "HCV, Hepatitis C virus, Religion, Religiosity, SF-36",
author = "Rajeev Raghavan and Laura Ferlic-Stark and Cinda Clarke and Manish Rungta and Richard Goodgame",
year = "2013",
doi = "10.1007/s10943-011-9455-y",
language = "English (US)",
volume = "52",
pages = "79--90",
journal = "Journal of Religion and Health",
issn = "0022-4197",
publisher = "Kluwer Academic/Human Sciences Press Inc.",
number = "1",

}

TY - JOUR

T1 - The Role of Patient Religiosity in the Evaluation and Treatment Outcomes for Chronic HCV Infection

AU - Raghavan, Rajeev

AU - Ferlic-Stark, Laura

AU - Clarke, Cinda

AU - Rungta, Manish

AU - Goodgame, Richard

PY - 2013

Y1 - 2013

N2 - To determine the influence of patient religiosity on the outcome of treatment of hepatitis C infection, a prospective, blinded, cohort study was performed on hepatitis C-infected patients categorized as 'higher religiosity' and 'lower religiosity' based on responses to a religiosity questionnaire. Comparisons were made between high and low religiosity patients on demographics, pre-treatment laboratory values, and response to treatment. Eighty-seven patients with complete questionnaires were placed in either higher (38) or lower (49) religiosity cohort. The patients (60% female) were ethnically diverse: African-American 39%; Hispanic 31%; white 29%. African-American race (P = 0. 001) and female gender (P = 0. 026) were associated with higher religiosity. The frequency of being offered treatment, accepting treatment, and completing treatment was similar in both religiosity cohorts (P = 0. 234, 0. 809, 0. 367). Fifty-six patients completed the 24- or 48-week treatment with peginterferon and ribavirin. Depression was more frequent in the low religiosity group (38. 2% vs. 4. 6%, P = 0. 005). Sustained viral response rate at 3-6-month post-therapy was similar in the higher (50%) and lower (57. 6%) religiosity cohorts (P = 0. 580; n = 55). Logistic regression modeling revealed that males having higher religiosity gave greater odds of SVR than those with lower religiosity (OR 21. 3; 95% CI 1. 1-403. 9). The level of religiosity did not affect the decision to begin treatment for chronic HCV infection and was not associated with a better treatment outcome. A higher level of religiosity was associated with less depression among patients.

AB - To determine the influence of patient religiosity on the outcome of treatment of hepatitis C infection, a prospective, blinded, cohort study was performed on hepatitis C-infected patients categorized as 'higher religiosity' and 'lower religiosity' based on responses to a religiosity questionnaire. Comparisons were made between high and low religiosity patients on demographics, pre-treatment laboratory values, and response to treatment. Eighty-seven patients with complete questionnaires were placed in either higher (38) or lower (49) religiosity cohort. The patients (60% female) were ethnically diverse: African-American 39%; Hispanic 31%; white 29%. African-American race (P = 0. 001) and female gender (P = 0. 026) were associated with higher religiosity. The frequency of being offered treatment, accepting treatment, and completing treatment was similar in both religiosity cohorts (P = 0. 234, 0. 809, 0. 367). Fifty-six patients completed the 24- or 48-week treatment with peginterferon and ribavirin. Depression was more frequent in the low religiosity group (38. 2% vs. 4. 6%, P = 0. 005). Sustained viral response rate at 3-6-month post-therapy was similar in the higher (50%) and lower (57. 6%) religiosity cohorts (P = 0. 580; n = 55). Logistic regression modeling revealed that males having higher religiosity gave greater odds of SVR than those with lower religiosity (OR 21. 3; 95% CI 1. 1-403. 9). The level of religiosity did not affect the decision to begin treatment for chronic HCV infection and was not associated with a better treatment outcome. A higher level of religiosity was associated with less depression among patients.

KW - HCV

KW - Hepatitis C virus

KW - Religion

KW - Religiosity

KW - SF-36

UR - http://www.scopus.com/inward/record.url?scp=84873523490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873523490&partnerID=8YFLogxK

U2 - 10.1007/s10943-011-9455-y

DO - 10.1007/s10943-011-9455-y

M3 - Article

VL - 52

SP - 79

EP - 90

JO - Journal of Religion and Health

JF - Journal of Religion and Health

SN - 0022-4197

IS - 1

ER -